Ono Pharmaceutical Co., Ltd. (OPHLY)

Ono Pharmaceutical Revenue

Ono Pharmaceutical had revenue of 134.22B JPY in the quarter ending December 31, 2024, with 2.31% growth. This brings the company's revenue in the last twelve months to 487.33B, down -2.16% year-over-year. In the fiscal year ending March 31, 2024, Ono Pharmaceutical had annual revenue of 502.67B with 12.41% growth.

• Revenue (ttm): 487.33B JPY
• Revenue Growth: -2.16%
• P/S Ratio: 1.75
• Revenue / Employee: 126.48M JPY
• Employees: 3,853
• Market Cap: 5.42B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	502.67B	55.49B	12.41%
Mar 31, 2023	447.19B	85.83B	23.75%
Mar 31, 2022	361.36B	52.08B	16.84%
Mar 31, 2021	309.28B	16.86B	5.77%
Mar 31, 2020	292.42B	3.79B	1.31%